BRAF and Miyoshi myopathy: Activating mutations in KRAS, NRAS and BRAF genes that encode proteins with a key role in the mitogen-activated protein kinase (MAPK) pathway have been reported in 23–26%, 20–24% and 4–6% of MM cases, respectively3, 4.